Erythropoiesis in vitro: enhancement by neuraminidase.
Neuraminidase treatment of human fetal liver or adult marrow cells prior to culture results in an increased number of erythroid colonies and bursts. No increase occurs in the number of nonerythroid colonies. The number of bursts having more than eight subunits is increased preferentially. Individual burst subunits are also enlarged. Neuraminidase-treated cells yield erythroid bursts when cultured in concentrations of erythropoietin insufficient to produce bursts from untreated cells. It is proposed that (1) neuraminidase treatment of adult and fetal cell mixtures specifically stimulates differentiation of erythroid precursors, (2) the preferential stimulation of erythroid bursts having many subunits suggests a preferential susceptibility of more primitive BFU-Es, and (3) neuraminidase treatment enhances the response of erythroid precursors to erythropoietin.
D001853:Bone Marrow / Q000187:drug effects; D002478:Cells, Cultured; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004920:Erythropoiesis / Q000187:drug effects*; D004921:Erythropoietin; D005333:Fetus; D006801:Humans; D008099:Liver / Q000187:drug effects; D009439:Neuraminidase / Q000494:pharmacology*
D004791:Enzyme Inhibitors; D004921:Erythropoietin; D009439:Neuraminidase